Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/18633
Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis.
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
One hundred and eighty nine patients with primary biliary cirrhosis were entered into a double blind, placebo controlled randomised trial starting in January 1978 to assess the therapeutic value of d-penicillamine 1200 mg daily. Eighteen of the 98 patients receiving d-penicillamine and 22 of the 91 placebo treated patients died during the study. Thirty six per cent of those on d-penicillamine and 8% of those on placebo were withdrawn from the study. No difference in overall survival was noted between the two groups of patients whether the results were analysed for the entire period of observation or only during the period in which the patients were receiving therapy. The mortality rate of those receiving d-penicillamine in histological stage I to II, however, was one third of that of the placebo group although this difference did not reach statistical significance. Using the occurrence rate ratio as the statistical method of analysis, no effect of d-penicillamine was noted on any clinical, biochemical or hist
Matèries
Matèries (anglès)
Citació
Col·leccions
Citació
NEUBERGER, J., CHRISTENSEN, E., PORTMANN, B., CABALLERIA ROVIRA, Joan, RODÉS, J., RANEK, L., TYGSTRUP, Niels, WILLIAMS, Roger. Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis.. _Gut_. 1985. Vol. 26, núm. 2, pàgs. 114-119. [consulta: 27 de gener de 2026]. ISSN: 0017-5749. [Disponible a: https://hdl.handle.net/2445/18633]